secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0000950170-23-066482
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex wins broader Medicare coverage for cyclophotocoagulation after LCD appeal
--------------------------------------------------------------------------------

- Five Medicare Administrative Contractors corrected CPC coverage criteria; 'AND' changed to 'OR', broadening patient access.
- Patient criteria now: failed trabeculectomy/tube shunt, minimal useful vision with elevated IOP, or need pain relief.
- CEO David Bruce thanked MACs for quick action; appeal supported by Dr. Shan Lin, co-author of the 2001 AAO paper.
- Iridex preparing subsequent appeal to further cover poor surgical candidates and emergency situations.
- Change aligns LCDs with 2001 AAO paper; Iridex cites 22 years of technological advances and clinical studies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000095017023066482/0000950170-23-066482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000095017023066482/irix-20231127.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-066482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer